Macular Edema Treatment Trials Associated with MUST (META-MUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Multicenter Uveitis Steroid Treatment (MUST) Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Macular Edema Treatment Trials Associated with MUST (META-MUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Replication fidelity mutants as attenuated poliovirus seeds for IPV production |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Mechansims of poliovirus replication |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Noncommunicable and/or Chronic Disease, Genetics |
|
|
Vaccine to Prevent HIV Infection in Pregnancy and Newborns |
Raul Andino-Pavlovsky, PhD |
HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health |
|
|
BSL3 upgrading for Live-attenuated poliovirus testing |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Mechanism of enterovirus replication |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development |
|
|
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Genetics, Risk Reduction and Prevention |
|
|
Protein homeostasis mechanisms underlying enterovirus replication and evolution |
Raul Andino-Pavlovsky, PhD |
Genetics |
|
|
RAPID: Ebola virus population structure, genetic diversity and evolution |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
RNAi as an Intercellular Antiviral Defense Mechanism |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Genetics |
|
|
A Collaborative Approach to the Design of a Genetically-Stable Oral Polio Vaccine (OPV-2) |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
INTERCEPT: Interfering and Co-evolving Prevention and Therapy |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Testing novel adjuvants to enhance mucosal immunity elicited by inactivated poliovirus vaccine (IPV) |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development, Immunology |
|
|
EV71 intra-host evolution, attenuation and vaccine development |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
2 year joint fellowship program in Clinical Pharmacy with Actelion |
Francesca Aweeka, PharmD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment, Residencies, Fellowships, and Postdoctoral Training |
|
|
LOC-IMPAACT Leadership Group |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development |
|
|
Escaneo genomico completo del paciente con diabetes tipo 2 para la busqueda de nuevos marcadores de asociacion con enfermedad |
Esteban Burchard, MD, MPH |
Diabetes, Genetics |
|
|
Genes, air pollution, and asthma severity in minority children |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Genetics |
|
|
Gene-Environment Analyses of Early Life Exposures and Asthma in Ethnically Diverse Children |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Occupational and Environmental Disease, Genetics, Pediatrics |
|
|
Whole Genome Analyses for Asthma in Latino Populations |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Occupational and Environmental Disease, Genetics |
|
|
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Genetics, Pharmacology and Drug Treatment, Pediatrics |
|
|
New York Center for Collaborative Research in Common Disease Genomics |
Esteban Burchard, MD, MPH |
Genetics |
|
|
Case-Control Association Studies and Genetic Confounding |
Esteban Burchard, MD, MPH |
Genetics, Risk Reduction and Prevention |
|
|
Center for Multi- and Trans-ethnic Mapping of Mendelian and Complex Diseases |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Genetics, Pediatrics |
|
|
Whole Genome Sequencing of Multiplex Schizophrenia Pedigrees from an Isolated Population |
William Byerley, MD |
Genetics, Neurology and Mental Health |
|
|
Genetics of Schizophrenia in Oceanic Palau |
William Byerley, MD |
Genetics, Neurology and Mental Health, Pediatrics |
|
|
An Automated High Throughput Phenotypic Screen for Schistosomiasis Drug Discovery |
|
Infectious Disease, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
A New Field Assay to Diagnose and Monitor Schistosomiasis |
|
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Automated smear-positive tuberculosis diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Evaluation of the performance of rapid, non-sputum based, biomarker-based test for tuberculosis (TB) diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Health Economics and Effectiveness |
|
|
Mobile Phone Platform for Genomic Disease Detection |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Genetics |
|
|
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Streamlined TB Diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus |
Henry Chambers, MD |
Genetics |
|
|
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia |
Henry Chambers, MD |
Infectious Disease, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
HVTN 703/HPTN 081 Protocol Funding (PF) |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health |
|
|
UZ-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning, Pediatrics, Newborn and Infant Health |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
HPTN 082 - Protocol Implementation Funding |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Parirenyatwa |
Zvavahera Chirenje, MD, FRCOG |
Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
Establishing a Core Facility for Virus Detection and Discovery |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Identification of Signaling Pathways Associated with Lyme Disease |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Simcere Surpi eval project |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Metagenomics for Identification of Infectious Triggers of KLS |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
Whole Blood/Serum Samples from Patients with Hepatitis |
Charles Chiu, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Identification of Viruses in an Asthma Cohort |
Charles Chiu, MD, PhD |
Chronic Respiratory Disease, Drug and Diagnostics Development |
|
|
Viral Discovery in Human and Animal Samples |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing |
Charles Chiu, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
CCD Study- RNA Sequencing |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Metagenomics for Detection and Discovery of Viruses Associated with Acute Gastroenteritis in Mexico |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Tissue Biopsy Samples from Head and Neck Cancers |
Charles Chiu, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages |
|
Tuberculosis, Immunology |
|
|
Secretion of Virulence Factors by Mycobacterium tuberculosis |
|
Infectious Disease, HIV/AIDS, Tuberculosis, Genetics |
|
|
Admixture Mapping Development and Testing in African American SLE |
|
Genetics |
|
|
Novel Strategies for defining the Role of HLA in SLE |
|
Noncommunicable and/or Chronic Disease, Genetics |
|
|
Dissecting the HLA Contribution to Rheumatoid Arthritis |
|
Genetics |
|
|
Immunogenetic Studies of Autoimmune Disease |
|
Immunology |
|
|
Dissecting the HLA contribution to Rheumatoid Arthritis |
|
Genetics |
|
|
Health Professional Research Preceptorship |
|
Immunology |
|
|
DNA methylation profiling in Rheumatoid Arthritis |
|
Immunology |
|
|
Mother-child genetic contributions to autoimmunity |
|
Immunology |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Medical and Graduate Student Preceptorship - Mok |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
A pilot study of DNA methylation and response to treatment in RA |
|
Immunology |
|
|
Epigenetic Profiling of Multiple Cell and Tissue Types in Sjögren's Syndrome |
|
Genetics |
|
|
Sputum Processing Methods |
|
Tuberculosis, Drug and Diagnostics Development |
|
|
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans |
|
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
HIV Controllers: A Potential Model for HIV Eradication |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
HIV Entry Inhibitors: A New Therapeutic Option |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Measuring the Latent reservoir for HIV |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Innate Effector Function and HIV-1 Control |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
T Regulatory Cells and T Cell Activation in HIV Disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
UCSF/Ragon Collaboration on HIV "Elite" Controllers |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics |
|
|
Elite Controllers |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Characterizing the Role of Immune Activation in HIV Persistence |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Enhancing Control of HIV by Inhibiting TRAIL |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Identifying and targeting HIV persistence in T Cell subsets during ART |
Steven Deeks, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
Combination immune checkpoint blocker inhibition to eliminate HIV latency |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients |
Steven Deeks, MD |
HIV/AIDS, Immunology, Women's Health |
|
|
Delaney AIDS Research Enterprise to Cure HIV |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Programming Long Term Durable HIV-1 Specific T cell Responses |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Novel Anti-Malarials by Combinatorial Pharmacogenomics |
Joseph Derisi, PhD |
Infectious Disease, Malaria, Drug and Diagnostics Development |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
CORE B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Tuberculosis, Immunology |
|
|
Core B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Integrative Program in Complex Biological System (ipCBS) |
Joseph Derisi, PhD |
Drug and Diagnostics Development, Immunology, Genetics, Residencies, Fellowships, and Postdoctoral Training |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients |
Maria Ekstrand, PhD |
HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence |
|
|
Microbial Pathogenesis and Host Defense |
Joanne Engel, MD, PhD |
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Adapting to a changing environment: How surface contact induces virulence factor production in Pseudomonas aeruginosa |
Joanne Engel, MD, PhD |
Genetics |
|
|
Novel approaches to identify host genes required for Chlamydia pathogenesis |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
High throughput proteomics to dissect Chlamydia-host cell interactions |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention |
|
|
Core Laboratory for Sputum Quality Assurance and Sputum Analysis |
|
Noncommunicable and/or Chronic Disease, Chronic Respiratory Disease, Drug and Diagnostics Development |
|
|
Preventing Fucose-Dependent Binding of Aspergillus and Pseudomonas to Lung Mucin |
|
Infectious Disease, Chronic Respiratory Disease, Genetics |
|
|
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Effector and regulatory T cell responses and protection from clinical malaria |
Margaret Feeney, MD |
Malaria, Drug and Diagnostics Development, Immunology |
|
|
VEGF signaling in placental development and disease |
Susan Fisher, PhD |
Immunology, Labor and Delivery |
|
|
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia |
Susan Fisher, PhD |
Genetics, Labor and Delivery |
|
|
Herpesviral Gene Expression in Kaposi's Sarcoma |
|
HIV/AIDS, Cancer/Oncology, Genetics |
|
|
Early Diagnosis of Human Prion Disease |
Michael Geschwind, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
The Amyotrophic Lateral Sclerosis (ALS)/Parkinsonism-Dementia Complex of Guam: Exploring the Mechanism of a Rare Tauopathy |
Michael Geschwind, MD, PhD |
Genetics, Neurology and Mental Health |
|
|
Multi-center evaluation of improved RT-QuIC diagnostic assays for Creutzfeldt-Jakob and other human prion diseases |
Michael Geschwind, MD, PhD |
Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
International Fellowship Program in Drug Development |
|
Drug and Diagnostics Development, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Development of Targeted Anti-Cancer Platinum Analogs |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Comprehensive Assay Platform and Database for Drug Transporter Interaction Studies |
|
Drug and Diagnostics Development |
|
|
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory |
Bryan Greenhouse, MD |
Malaria, Immunology, Pediatrics |
|
|
Hologic - Analytical sensitivity comparison of a new molecular assay for Plasmodium detection with a qualitative nested PCR assay and a quantitative PCR assay 20150330 |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Biomarkers for Malaria Eradication (BIOME) |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults |
Bryan Greenhouse, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Malaria Serology evaluation |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Treating HIV-Infected Elite Controllers as a Model of HIV Remission |
|
HIV/AIDS, Immunology |
|
|
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients |
|
HIV/AIDS, Immunology |
|
|
Task Order Agreement No. CRB-DCR01-S-09-00325 |
Diane Havlir, MD |
Drug and Diagnostics Development |
|
|
ACTG A5335s Specialty Lab |
Diane Havlir, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" |
Philip Hopewell, MD |
Tuberculosis, Immunology, Systematic Reviews and Guideline Development |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
|
HIV/AIDS, Immunology |
|
|
UCSF-FIND Uganda Project |
Laurence Huang, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Valganciclovir to Reduce T Cell Activation in HIV Infection |
Peter Hunt, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Immunologic determinants of age-related macular degeneration |
Peter Hunt, MD |
Eye Disease and Blindness, Immunology, Aging |
|
|
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV |
Peter Hunt, MD |
HIV/AIDS, Immunology |
|
|
Mesalamine to Reduce T Cell Activation in HIV Infection |
Peter Hunt, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Peter Hunt, MD |
Immunology |
|
|
Investigating Mechanisms of HIV Persistence in the Gut |
Peter Hunt, MD |
HIV/AIDS, Immunology |
|
|
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations |
Vivek Jain, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Improving the molecular diagnosis of drug resistant tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Funding-NSW-QB3 Rosenman Institute Scholarship Program |
Regis Kelly, MD |
Drug and Diagnostics Development, Residencies, Fellowships, and Postdoctoral Training |
|
|
QB3 Entrepreneurship, Train the trainers program |
Regis Kelly, MD |
Drug and Diagnostics Development, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
NSW-QB3 Rosenman Institute Scholarship Program |
Regis Kelly, MD |
Drug and Diagnostics Development, Residencies, Fellowships, and Postdoctoral Training |
|
|
QB3 Entrepreneurship Programs |
Regis Kelly, MD |
Drug and Diagnostics Development |
|
|
Alcohol's impact on immunological and virological profiles in HIV patients |
Mandana Khalili, MD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis |
Mandana Khalili, MD |
Immunology |
|
|
Identification of the CD8+ Cell Anti-HIV Factor (CAF) |
|
HIV/AIDS, Immunology |
|
|
HIV cure with CCR5 negative human IPS hematopoietic stem cells |
|
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Initiation of Allergic Immunity by Parasites |
Richard Locksley, MD |
Immunology |
|
|
Initiation of allergic immunity by parasites |
Richard Locksley, MD |
Immunology |
|
|
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia |
|
Immunology |
|
|
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma |
|
Occupational and Environmental Disease, Immunology |
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Regulation of Human Thymic Function in Vivo |
Mike McCune, MD, PhD |
Immunology |
|
|
Recent Thymic Emigrants of the CD4 T-Cell Lineage |
Mike McCune, MD, PhD |
Immunology |
|
|
Timing of ART and homeostasis of the persistent HIV reservoir in the adult |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology |
|
|
Interferon-independent mechanisms of malaria restriction by helper T cells |
Mike McCune, MD, PhD |
HIV/AIDS, Malaria, Immunology |
|
|
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology |
|
|
The impact of TB co-infection on the reservoir of persistent HIV in vivo |
Mike McCune, MD, PhD |
HIV/AIDS, Tuberculosis, Immunology |
|
|
Defining critical events in early HIV infection-effects of alcohol and early ART |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
Targeting Cysteine Proteases--Antiparasitic Chemotherapy |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
High Throughput Assay for Screening Compounds Against T. Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Developing a Macrofilaricidal Drug for Onchocerciasis Using Anacor's Novel Oxaborole Technology |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Host Protein Degradation by Schistosome Parasites |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
K777 for the Treatment of Chagas' Disease, IND-enabling Studies and IND Submission |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Schistosome Research |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Identification and Validation of Targets of Phenotypic High Throughput Screening |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Trypanosome Drug Development Consortium |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Evaluation of a Novel Automated PCR Method for Infectious Disease Diagnostics |
|
Drug and Diagnostics Development |
|
|
Deep Sequencing Clinical Analysis Tool for Infectious Disease |
|
Infectious Disease, Drug and Diagnostics Development |
|
|
Develop Clinical Evidence of Substantial Equivalence to Predicate Devices |
Suellen Miller, PhD, CNM, MHA |
Drug and Diagnostics Development |
|
|
Sputum Transcriptomic Expression Profiling in Study 31 (STEPS 31) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo |
Payam Nahid, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Tuberculosis Trials Consortium (TBTC) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Chemoprophylaxis and HIV-Host Interactions [II] |
|
HIV/AIDS, Immunology |
|
|
Immunological Targeting of APOBEC Proteins to Cure HIV Infection |
|
HIV/AIDS, Immunology |
|
|
New therapeutic HPV vaccines for HIV-infected men and women |
Joel Palefsky, MD |
Genetics |
|
|
Pharmacogenomics of Antimalarial Drugs |
Sunil Parikh, MD, MPH |
Malaria, Genetics, Pharmacology and Drug Treatment |
|
|
HIV Incidence Testing in Hair |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence |
|
|
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Wave 80 Fingerstick Pilot Study |
Christopher Pilcher, MD |
Drug and Diagnostics Development |
|
|
Structure and Engineering of Natural Product Cytochrome P450 |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Cross-Sectional Examination of Cerebrospinal Fluid Kinetic Biomarkers of Axonal Transport for Amyotrophic Lateral Sclerosis (Als) Diagnosis and Progression |
Richard Price, MD |
Drug and Diagnostics Development |
|
|
CNS Immune / Inflammatory Biomarkers in HIV Controllers |
Richard Price, MD |
HIV/AIDS, Immunology |
|
|
Discovering Drugs for Prion Diseases |
|
Drug and Diagnostics Development |
|
|
Towards Therapeutics for Neurodegenerative Diseases |
|
Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
Characterization of Familial Advanced Sleep Phase Syndrome |
Louis Ptacek, MD |
Genetics |
|
|
Genetic and molecular pathophysiology of ATS |
Louis Ptacek, MD |
Cardiovascular Disease, Genetics |
|
|
Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS) (Survey ID: Fx-R-001) |
Jeffrey Ralph, MD |
Genetics, Neurology and Mental Health |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Precision Targeting of Castration Resistant Prostate Cancer with a Novel Ferrous Iron-Dependent Therapeutic Delivery and Tumor Imaging Strategy |
Adam Renslo, PhD |
Cancer/Oncology, Immunology |
|
|
Novel Linkers for Antibody-Drug Conjugates |
Adam Renslo, PhD |
Immunology |
|
|
Evolution and Inhibition of Serine Beta-Lactamase Activity |
Adam Renslo, PhD |
Opportunistic Infection, Drug and Diagnostics Development |
|
|
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Identification of Novel Therapeutics Molecules against Old and New World Cutaneous Leishmaniasis |
Adam Renslo, PhD |
Drug and Diagnostics Development |
|
|
RNA Interference and High-Content Image Analysis to Discover New Drug Targets to Treat the Tropical Disease Schistosomiasis |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go) |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Development of Falcipain Inhibitors as Antimalarial Drugs |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Chemicals with Potential Activity against Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Discovery of benzoxaboroles for the treatment of cryptosporidiosis |
Philip J. Rosenthal, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [I] |
Philip J. Rosenthal, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Development of Antimalarial Drug Leads Through Inhibition of Food Vacuole Falcipains |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Valley Fever Vaccine Project 2010 |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Valley Fever Vaccine Project |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Point-of-Care Diagnostics for STI and UTI |
Julius Schachter, PhD |
Drug and Diagnostics Development |
|
|
A smartphone-based point-of-care test for detection of Chlamydia trachomatis |
Julius Schachter, PhD |
Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
A point of care assay for chlamydia to assure prompt treatment in at risk minorities |
Julius Schachter, PhD |
Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Detection of C. trachomatis on eye swabs |
Julius Schachter, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Disease susceptibility and global distribution of genetic variation |
Mark Seielstad, PhD |
HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Metagenomic Contributions to Type 2 Diabetes Among Filipino Populations |
Mark Seielstad, PhD |
Transfusion Medicine, Diabetes, Genetics, Epidemiology and Surveillance |
|
|
Genetics of Brazilian Populations |
Mark Seielstad, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines |
Mark Seielstad, PhD |
Infectious Disease, Transfusion Medicine, Immunology, Pharmacology and Drug Treatment, Pediatrics, Epidemiology and Surveillance |
|
|
Dual Energy X-Ray Absorptiometry (DXA) Scan Analysis and Quality Control Review for NHANES 2011-2016 |
|
Drug and Diagnostics Development |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Elizabeth Sinclair, PhD |
HIV/AIDS, Immunology |
|
|
Origami Female Condom User-Preference (FUP) Study |
|
Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women |
Phyllis Tien, MD |
Infectious Disease, HIV/AIDS, Immunology, Women's Health |
|
|
EBV BMRF-2 Protein in Infection of Oral Epithelial Cells |
Sharof Tugizov, PhD |
Noncommunicable and/or Chronic Disease, Drug and Diagnostics Development |
|
|
Creating Maps of 4D Brain Images to Unravel Dementia Heterogeneity of Aging HIV Population |
Victor Valcour, MD, PhD |
Drug and Diagnostics Development, Dementia and Cognitive Impairment |
|
|
Microbicide Pregnancy Registry-Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
amfAR Institute for HIV Cure Research |
Paul Volberding, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
CHRP Disparities Initiative: UCSF CFAR Conference Award |
Paul Volberding, MD |
HIV/AIDS, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Double-Stranded RNA Virus in Giardia |
|
Genetics |
|
|
Translation Regulation in Giardia lamblia |
|
Infectious Disease, Genetics |
|
|
An optogenetic method to rapidly and reversibly titrate protein levels in cells |
|
Genetics |
|
|
Antigen Decoding by T cells |
|
Immunology |
|
|
Advancing New Methodologies to Measure Patient Preference for Regulatory Approval of Devices |
Leslie Wilson, PhD, MS |
Drug and Diagnostics Development |
|
|
Development, Assessment And Validity Comparison Of Approaches To Eliciting Patient Preferences Across Risk Groups: A Case Study On Innovative Preference Sensitive Treatments (Type 1 Diabetes Or Hereditary Retinal Dystrophy Or Osteoarthritis) |
Leslie Wilson, PhD, MS |
Diabetes, Genetics |
|
|
Biomarkers for PTSD in Female Iraq and Afghanistan Veterans |
|
Drug and Diagnostics Development, Trauma and PTSD |
|
|
A Program of Research in Population Cytogenetics |
Tracey Woodruff, PhD, MPH |
Occupational and Environmental Disease, Genetics, Newborn and Infant Health |
|
|
Clinical Pharmacology, Drug Action and Pharmacogenetics |
Neal Benowitz, MD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Naturally acquired immunity to norovirus in a newborn cohort in Peru |
Caryn Bern, MD, MPH |
Infectious Disease, Immunology, Newborn and Infant Health |
|
|
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) |
|
Opportunistic Infection, Drug and Diagnostics Development |
|
|
Mechanisms of nanostructure-enhanced transepithelial drug delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
UCSF/UCB Joint Graduate Group in Bioengineering |
Tejal Desai, PhD |
Drug and Diagnostics Development, Residencies, Fellowships, and Postdoctoral Training |
|
|
Nanostructured Polymer Films and Microneedles |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Nanoengineered Thin Film Devices for Ocular Drug Delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Nanoporous Films for Ocular Drug Delivery |
Tejal Desai, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Nanoporous Capsules for the Investigation of Macroencapsulation Parameters |
Tejal Desai, PhD |
Diabetes, Drug and Diagnostics Development |
|
|
Nanoscale Science and Engineering Center (NSEC) |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Micro- and Nano-Structured Biopolymer Thin Film Devices for Small Molecule Drug Delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Gilead HCAT Support-SOMA Project |
James Dilley, MD |
Genetics |
|
|
Time to negativity of Plasmodium falciparum histidine-rich protein 2 rapid diagnostic tests (RDT) in Zambezi region Namibia |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Donation of Primaquine for the UCSF-Sponsored Phase 2A Dose Escalation Study of the Efficacy, Safety and Pharmacokinetics of Low Single-Dose Primaquine for Gametocytocidal Activity against P. Falciparum in Sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Host Genetics of HIV: Enhancing Discovery through Study Design and New Tools |
Ruth Greenblatt, MD |
HIV/AIDS, Genetics |
|
|
Exploiting Genomic or Nucleomic Information to Understand HIV Latency in Individuals with Substance Use Disorders |
Ruth Greenblatt, MD |
HIV/AIDS, Genetics, Substance Abuse |
|
|
Molecular Methods for Cervical Cancer Screening in HIV+ Women |
Nancy Hessol, MSPH |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria, Drug and Diagnostics Development |
|
|
Newborn Screening Program for Sickle Cell |
James Huang, MD |
Genetics, Newborn and Infant Health |
|
|
Public Health Research, Epidemiology, and Surveillance for Hemoglobinopathies (PHRESH) Sickle Cell Disease (SCD)/ Thalassemia Case Reporting |
James Huang, MD |
Infectious Disease, Genetics, Health Systems Strengthening, Risk Reduction and Prevention |
|
|
Global Innate Immune Responses to HIV-1 Infection |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
Physical and Genetic Interaction Landscape of the Tyrosine Kinome |
Nevan Krogan, PhD, MSc |
Cancer/Oncology, Diabetes, Immunology |
|
|
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach |
Nevan Krogan, PhD, MSc |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics |
|
|
Integrating computation and genetics to quantify specificity in protein networks |
Nevan Krogan, PhD, MSc |
Genetics |
|
|
Host-pathogen interactions: Unveiling common mechanisms for rewiring host factors in infectious processes |
Nevan Krogan, PhD, MSc |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
HPMI: Host Pathogen Mapping Initiative |
Nevan Krogan, PhD, MSc |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
HINT: HIV Immune Networks Team Modeling Core |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
HIV Vaccine Trials Network - Laboratory Personnel Support |
|
Immunology |
|
|
Probing Below the Surface: Development of a Molecular Diagnostic Assay to Detect Emergent Viral Escape Variants |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Ultra-Low Viral Detection Using the Abbott RealTime HIV-1 Assay |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Collaborative Molecular Genetic Investigation of Pediatric Myelodysplatic Syndromes |
|
Genetics, Neurology and Mental Health |
|
|
PAAR4Kids-Pharmacogenomics Research Network |
|
Cancer/Oncology, Genetics, Pharmacology and Drug Treatment |
|
|
Diagnostic Antibody for Type A Botulism |
|
Infectious Disease, Drug and Diagnostics Development |
|
|
Generation of therapeutic antibodies for serotype F botulism (Continuation of A120963 from NIH G Pool to Subaccount) |
|
Immunology |
|
|
Improve the Cho Expression of a ScFv Fragment by Optimizing the DNA Sequence of the ingle chain variable fragment ScFv and/or Leader Sequence |
|
Drug and Diagnostics Development, Immunology |
|
|
Sanofi-Aventis SAR650894 Program - Research Component |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Identifying Intermediate Phenotypes for Compulsive Hoarding |
Carol Mathews, MD |
Genetics, Neurology and Mental Health |
|
|
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-Daily Oral Aripiprazole in Children and Adolescents with Tourette's Disorder |
|
Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health |
|
|
Mechanisms of Skeletal Stem Cell Dysfunctions in Traumatic Bone Injuries |
Theodore Miclau, MD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Aqueous-PREP: A Pragmatic Randomized trial Evaluating Pre-operative aqueous antiseptic skin solutions in open fractures |
Saam Morshed, MD, MPH, PhD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Clinical Trial of the Infuse/Mastergraft Delayed Healing Device with Rigid Internal Fixation in the Treatment of Tibial Delayed Healing ("Tibia Study") |
Saam Morshed, MD, MPH, PhD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Philips Mra Research Plan B-9 (Dose Aware) |
Saam Morshed, MD, MPH, PhD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Whole Genome Sequencing in Multiple Sclerosis |
|
Genetics |
|
|
Mechanism, Specificity, and Inhibition of Cytochrome P450 |
|
Drug and Diagnostics Development, UCSF Professional Education |
|
|
Creating Polyketide Antibiotic Diversity by Engineering Cytochrome P450 Enzymes / UC Discovery |
|
Immunology |
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis |
|
Tuberculosis, Immunology |
|
|
Structural Biology and Targeted Drug Design for AIDS |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Selective Destruction of Cytochrome P450 by Drugs |
|
Drug and Diagnostics Development |
|
|
Fellowship in Clinical Biochemical Genetics |
|
Genetics, Residencies, Fellowships, and Postdoctoral Training |
|
|
Lysosomal Storage Disorders Genetic Counselor Fellowship (Genzyme 43737) |
|
Noncommunicable and/or Chronic Disease, Genetics, Pediatrics |
|
|
Mechanisms of Spatial Cognitive Impairment in Neurodegenerative Disease |
|
Drug and Diagnostics Development, Dementia and Cognitive Impairment |
|
|
Genetic Determinants of Capecitabine Toxicity |
|
Genetics, Pharmacology and Drug Treatment |
|
|
Lesion Drug Penetration and Translational Modeling |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Phase III Quinolone Meta-Analysis |
Rada Savic, PhD |
Drug and Diagnostics Development |
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Epi4K: Gene discovery in 4,000 Epilepsy Genomes (4/7) |
Elliott Sherr, MD, PhD |
Cardiovascular Disease, Genetics |
|
|
ACC: Callosal Agenesis as a Window into Common Neurodevelopment Disorders |
Elliott Sherr, MD, PhD |
Genetics, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
International Collaboration in Chemistry: the Chemical Basis for Allosteric Regulation of G Protein Coupled Receptors |
|
Drug and Diagnostics Development |
|
|
A Web-Based Automatic Virtual Screening System |
|
Genetics |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Drug and Diagnostics Development |
|
|
A Web-Based Automatic Virtual Screening System |
|
Drug and Diagnostics Development |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Immunology |
|
|
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism |
|
Genetics |
|
|
Reducing Breast Cancer Risk in Korean American Women |
Janice Tsoh, PhD |
Cancer/Oncology, Genetics, Immigration and Migration |
|
|
NP25737 A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis |
|
Noncommunicable and/or Chronic Disease, Immunology, Pediatrics |
|
|
Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA Registry): Lupus Nephritis Consensus Treatment Plan Maintenance Phase |
|
Immunology |
|
|
A 6 month Multi-center, Open-label Safety Study of VIMOVO in Adolescents |
|
Immunology, Adolescent Health |
|
|
Mechanisms of B Cell Responses in Autoimmune Disease: C12-ALE05-CSF |
|
Immunology |
|
|
Sensitivity of Electronic Alcohol Diagnosis |
Constance Weisner, DrPH |
Drug and Diagnostics Development |
|
|
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence |
Constance Weisner, DrPH |
Drug and Diagnostics Development, Substance Abuse |
|
|
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling |
Sulggi Lee, MD |
HIV/AIDS, Immunology |
|
|
Neuroform Angiographic Analysis (Subset of MAPS study data) |
|
Cardiovascular Disease, Drug and Diagnostics Development |
|
|
Multimodal Imaging of Antibody-Mediated Therapy for Japanese Encephalitis Virus |
Michael Wilson, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Viruses in Breast Fluid: Biomarkers for Breast Cancer? |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Provider Practices in Non-Malarial Fevers: A Pilot Study in Malawi |
Kimberly Baltzell, RN, PhD, MS |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Nursing education in malarial settings |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development, Implementation and Behavioral Science, Engagement in Care, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Non- P falciparum and mixed species malarial infection in Zanzibar |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development |
|
|
Pivotal Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea |
|
Drug and Diagnostics Development |
|
|
Development of Human mAbs to Target Cardiomyocytes and Cardiac Fibroblasts |
|
Cardiovascular Disease, Immunology |
|
|
Development of Human mABs to CXCR1 and CXCR2 |
|
Immunology |
|
|
Life After Pediatric Sepsis Evaluation, LAPSE |
|
Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
HLA-A Low Resolution Typing |
|
Surgery and Anesthesia, Immunology |
|
|
Molecular basis of tissue interactions that regulate craniofacial development |
|
Genetics |
|
|
The Role of Continuous Phenotypic Variation in Structural Defects of the Face |
|
Genetics, Newborn and Infant Health |
|
|
Bioresponsive Scaffold Designed to Promote Bone Regeneration Through a Cartilage Intermediate |
|
Drug and Diagnostics Development |
|
|
Collaborative Network for Clinical Research on Immune Tolerance - Offcampus Portion |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Collaborative Network for Clinical Research on Immune Tolerance |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Development of Regulatory T-Cells for Treatment of Autoimmune Disease |
Jeffrey Bluestone, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
Phase II Double Blinded, Placebo-Controlled, Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an Anti-IgE mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
UCSF Comprehensive Center for Immunologic Diseases (CCID) |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Immunomodulation of transplant rejection by anti-CD3 mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Antigen Specificity of Regulatory T cells in Type 1 diabetes T1D |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Mechanisms of Neutrophil Activation |
|
Immunology |
|
|
Regulation of Innate Immune Signaling by Lyn Kinase |
|
Immunology |
|
|
Identifying Human Breast Carcinogens Using Exposomics |
Laura Fejerman, PhD |
Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Genome wide association study of breast cancer subtype and survival in Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Genetics, Epidemiology and Surveillance |
|
|
Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer |
Katherine Van Loon, MD, MPH |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Preparing for Human Studies Using the Spinlab Polarizer |
|
Drug and Diagnostics Development |
|
|
DSC09r-178688 GEH Novel MR Technology (7T & C13) |
|
Drug and Diagnostics Development |
|
|
MR Metabolic Imaging of Response to Targeted Therapies in GBM |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Zika virus infection using models of the human placenta |
Lenore Pereira, PhD |
Immunology, Newborn and Infant Health |
|
|
Investigating ASPM regulation of asymmetric division for therapeutic opportunities |
|
Genetics |
|
|
Image-Based Numerical Predictions of Hemodynamics following Vascular Intervention |
David Saloner, PhD |
Cardiovascular Disease, Drug and Diagnostics Development, Neurology and Mental Health |
|
|
Stem Cell differentiation to thymic epithelium for inducing immune tolerance to stem cells |
|
Immunology |
|
|
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis |
Felicia Chow, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Alfred P. Sloan Foundation Fellowship |
|
Genetics |
|
|
Rhbmp2 vs. AutograpH for Critical Size Tibial Defects: a Multi-Center Randomized Trial |
Amir Matityahu, MD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Targeting BET-bromodomains in neuroblastoma |
|
Cancer/Oncology, Drug and Diagnostics Development, Pediatrics |
|
|
Murine Neuroblastoma Models for Preclinical Therapeutics |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Using Genetics and Genomics to Dissect Coccidioides Spherulation |
Anita Sil, MD, PhD |
Genetics |
|
|
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma |
Anita Sil, MD, PhD |
Opportunistic Infection, Immunology |
|
|
UC Valley Fever Research Initiative |
Anita Sil, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Genetics |
|
|
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness |
|
Cancer/Oncology, Immunology |
|
|
Gilead Sciences Research Scholars Program in Cystic Fibrosis. |
Oren Rosenberg, MD, PhD |
Immunology |
|
|
Janssen/Sakanari - flubendazole study 20150930 |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Examination of genome instability in Plasmodium Falciparum using functional genomics |
|
Malaria, Genetics |
|
|
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation. |
Lydia Zablotska, MD, MPA, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Optimization of health care expenditures to maximize societal value |
Dhruv Kazi, MD, MSc, MS |
Cardiovascular Disease, Drug and Diagnostics Development, Health Economics and Effectiveness |
|
|
A feasibility study evaluating a reservoir storage system for continuous oxygen delivery in Uganda |
Melissa Morgan Medvedev, MD, MSc, PhD |
Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Trefoil Factors Regulate Th2 Immunity |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology |
|
|
Trefoil Factor Proteins Modulate Host Immunity against Hookworms |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Treatment of SLE with ajulemic acid,a non-psychoactive cannabinoid derivative |
|
Immunology |
|
|
Self-Assembled DNA Devices for Nanoscale Manipulation of Immune Signal Transduction |
|
Drug and Diagnostics Development |
|
|
Large-Scale Production and In-Vivo Characterization of Therapeutic DNA Nanodevices |
|
Drug and Diagnostics Development |
|
|
Neurosteroids in Health and Disease |
|
Genetics, Neurology and Mental Health |
|
|
Improving the efficiency of clinic-based active tuberculosis case finding: point-of-care C-reactive protein-based TB triage testing in Vietnam |
Christina Yoon, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Designing a Sonographic Medium for Low Resource Settings |
|
Drug and Diagnostics Development |
|
|
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis |
|
Tuberculosis, Immunology |
|
|
A Novel Myeloid Subset Mediating Tolerance to Malaria |
|
Malaria, Immunology |
|
|
Fever Etiology and Prognostic Point-of-Care Biomarkers in African Children with Severe Febrile Illness |
Teresa Bleakly Kortz, MS, MD |
Drug and Diagnostics Development |
|
|
Reactivation of latent HIV using recombinant galectin-9 |
|
HIV/AIDS, Immunology |
|
|
Barriers to point-of-care G6PD testing for P.vivax malaria in Malaysia: a qualitative study |
Jessica Jaswal, MS |
Malaria, Drug and Diagnostics Development, Access or Barriers to Care |
|
|
Biocompatibility of Implantable Renal Replacement Devices |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
DHHS Intracorporeal Ultrafiltration System and Intracorporeal Hemodialysis System |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
An implantable hemodialyzer for treatment of End-Stage Renal Disease |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Flexible Resorbable Organic and Nanomaterial Therapeutic Systems (FRONTS) |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Building an Implantable Artificial Kidney |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Intervascular Capsule for Islet Transplantation in Type I Diabetic Patients |
Shuvo Roy, PhD |
Diabetes, Drug and Diagnostics Development |
|
|
Silicon Dialyzer Prototype |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
The Ethics of Inclusion: Diversity in Precision Medicine Research |
Janet K. Shim, PhD |
Genetics |
|
|
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) |
Michael Harrison, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians |
|
|
UCSF-Stanford Pediatric Device Consortium |
Michael Harrison, MD |
Drug and Diagnostics Development, Pediatrics |
|
|
California Precision Medicine Consortium |
Atul Butte, MD, PhD |
Drug and Diagnostics Development |
|
|
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology |
Atul Butte, MD, PhD |
Cancer/Oncology, Immunology |
|
|
INS011-14-029: A Phase 1/2 study to assess the pharmacokinetics and safety of multiple doses of pharmaceutical Cannabidiol Oral Solution in pediatric subjects with treatment-resistant seizure disorders |
|
Drug and Diagnostics Development, Neurology and Mental Health, Pediatrics |
|
|
Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Dravet Syndrome |
|
Drug and Diagnostics Development, Neurology and Mental Health |
|
|
Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric and Adult Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029, INS011-14-024, or INS011-14-25 |
|
Drug and Diagnostics Development, Neurology and Mental Health, Pediatrics |
|
|
A Technological Platform for the Identification of Serine Proteases in Cancer |
Charles Craik, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Identification of Cobra-specific antibodies |
Charles Craik, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Targeting Allosteric Sites to Modulate Protein Interactions and Function |
Charles Craik, PhD |
Drug and Diagnostics Development |
|
|
Allosteric Inhibition of a Family of Proteolytic Enzymes |
Charles Craik, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
A Technological Platform for the Identification of Serine Proteases in Cancer |
Charles Craik, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
An Ultrasensitive in Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Single Cell Characterization of Latent HIV-1 Reservoirs |
|
HIV/AIDS, Immunology |
|
|
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin |
|
HIV/AIDS, Immunology |
|
|
Impact of Sirolimus (Rapamycin) on HIV-1 Persistence and Immune Function |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
HIV Cures - Paving the way towards elimination of HIV persistent CD4 T cell in vivo |
|
HIV/AIDS, Immunology |
|
|
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel with or without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Optogenetic dissection of the growth and activation network in T cells |
|
Immunology |
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Genetics |
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
Understanding Ciliary Functions in Mammalian Development |
Jeremy Reiter, MD, PhD |
Genetics |
|
|
Transition zone control of ciliary signaling |
Jeremy Reiter, MD, PhD |
Genetics |
|
|
Screening for kidney disease |
Michael Shlipak, MD |
Drug and Diagnostics Development |
|
|
p24 Antigen and Alternative Markers in Infants, Vietnam |
Annette Sohn, MD |
HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Validation of candidate ASD genes by targeted sequencing with molecular inversion probes |
|
Genetics, Neurology and Mental Health |
|
|
1/3 Multidimensional investigation of the etiology of autism spectrum disorder |
|
Genetics, Neurology and Mental Health |
|
|
3/3 Integrative Genomic Analysis of Human Brain Development and Autism |
|
Genetics, Neurology and Mental Health |
|
|
2/2 - Cell Type and Region-Specific Regulatory Networks in Human Brain Development and Disorders |
|
Genetics, Neurology and Mental Health |
|
|
2/7-Collaborative genomic studies of Tourette Disorder |
|
Genetics, Neurology and Mental Health |
|
|
Extending ASD risk locus discovery to the non-coding genome |
|
Genetics, Neurology and Mental Health |
|
|
Multi-Institutional Randomized Controlled Trial Evaluating Use of Arista Absorbable Surgical Hemostatic Powder |
Rahul Seth, MD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Utility of Rapid Diagnostic Tests for Malaria |
|
Malaria, Drug and Diagnostics Development, Pediatrics |
|
|
Hepatic degradation of cytochrome P450 enzymes |
Maria Correia, PhD |
Drug and Diagnostics Development |
|
|
Influence of Heme on Hepatic Cytochrome P450 Turnover |
Maria Correia, PhD |
Drug and Diagnostics Development |
|
|
Closing the gap between observational research and randomized trials for prevention of Alzheimer's Disease and dementia |
Maria Glymour, ScD, MS |
Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
Diagnostic Imaging Core Laboratory Services: Ischemic Stroke Neuroflow Study, Vasospasm Subjects |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
3D-FSE-zeta equipment |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
Solitaire With the Intention For Thrombectomy (SWIFT) Study |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
UCSF- Kenyan radiology residency training |
William Dillon, MD |
Drug and Diagnostics Development, Training and Capacity Building, Training International Scholars and Clinicians, Distance learning and mentoring |
|
|
HARC Center: HIV Accessory and Regulatory Complexes |
Alan Frankel, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology |
|
|
Biomedical simulation models describing how molecular level events effect changes in phenotype |
C. Anthony Hunt, PhD |
Immunology, Genetics |
|
|
Population Genetics of the PO1 Locus of SIV and HIV-1 |
Eric Delwart, PhD |
HIV/AIDS, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Effects of Viral Escape on Memory T-Cell Muturation |
Eric Delwart, PhD |
Immunology |
|
|
Viral metagenomics to discover viruses |
Eric Delwart, PhD |
Transfusion Medicine, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Developing an breast FNA biopsy service in Trujillo Peru |
Ronald Balassanian, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Genomic research on the African diaspora |
Ian Whitmarsh, PhD |
Genetics |
|
|
Pilot Testing, Refinement, and Validation of the Infrastructure to Develop -RADS-based Registries |
Marc Kohli, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Developing new vaccines for Global Health applications |
|
Drug and Diagnostics Development, Immunology |
|
|
Transfusion science and HIV, HTLV, and dengue research in Brazil |
Philip Norris, MD |
Infectious Disease, HIV/AIDS, Immunology, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building |
|
|
Immunology & epidemiology of intestinal infectious diseases |
Robert Owen, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance |
|
|
Patient beliefs about the relationship between Chronic Non-Cancer Pain (CNCP) management, alcohol and marijuana use in safety net, primary health care settings |
Jorge Ramirez, MD, MPH, MS |
Drug and Diagnostics Development |
|
|
Snakebite treatment in Nepal |
Tommaso Bulfone, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Antimalarial drugs in Ugandan populations |
Melissa Conrad, PhD |
HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
Sustained Strengthening of Public Health Laboratory, Transfusion Services and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
Kayla Enriquez, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Drug and Diagnostics Development, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training International Scholars and Clinicians |
|
|
MicroRNAs Circulantes Asociados Con Riesgo De Diabetes En Latinos |
Elena R. Flowers, PhD, RN |
Diabetes, Drug and Diagnostics Development |
|
|
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis |
Emma Gunderson, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Understanding the epidemiology and natural history of unrecognized Ebola virus infection |
Dan Kelly, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Population genetic analysis and regional variation |
Kicheol Kim, PhD |
Genetics |
|
|
Bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples |
Taylor Sittler, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos Burroughs Wellcome Fund |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Vertical Transmission of Zika Virus: Histopathological Investigations at the Maternal- Fetal Interface |
Stephanie Valderramos, MD, PhD |
Infectious Disease, Drug and Diagnostics Development, Immunology |
|
|
Placental malaria: The role of inflammation at the maternal-fetal interface |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology, Labor and Delivery, Newborn and Infant Health |
|
|
Chlamydial sexually transmitted diseases and trachoma |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Incidence, Prevalence and Risk Factors for Sexually Transmitted Infections in Fiji |
Deborah Dean, MD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
Natural Bacteriocins as Pre/Pro-Biotics to Promote Oral Health and Prevent Periodontal Disease |
Yvonne Kapila, DDS, PhD |
Oral Health, Drug and Diagnostics Development |
|
|
Validation of the GeneXpert Breast Cancer STRAT4 Assay for Rapid Analysis of Breast Cancer Biomarker Status from Fine Needle Aspiration Biopsies in Tanzania (GX-BCB |
Dianna Ng, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Developing and adapting innovative diagnostic assays for low-resource settings |
Dianna Ng, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Quantitative mapping of interactions between dengue virus and its hosts |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains |
Sumayya Mohammed, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics |
|
|
Factors Associated with G6PD Deficiency Testing Adherence Among P. vivax RDT-positive Individuals Living in Southern Lao PDR |
Resego Bokete, MS |
Malaria, Drug and Diagnostics Development |
|
|
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis |
Jennifer Chen, MD |
Immunology |
|
|
IgA regulation of mucosal biome |
Keith Mostov, MD, PhD |
Immunology |
|
|
Interventions to Improve Non-Malarial Fever Diagnosis in Mobile Health Clinics in Mulanje, Malawi |
Fiona Sylvies, MS |
Infectious Disease, Drug and Diagnostics Development |
|
|
Dissecting the effect of paracrine responses to Zika virus on neurodevelopment in the human brain |
Hanna Retallack, AB |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Clinical trials to improve the treatment of drug-sensitive and MDR-TB |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Immunology, Pharmacology and Drug Treatment |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development, Pediatrics |
|
|
Improving urine-based tuberculosis diagnosis in people living with HIV |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Role of Antigen-Specific T Cell Responses in the Control of TB |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Antigen export in M. tuberculosis evasion of CD4 T cells |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Cellular and Bacterial Dynamics in Tuberculosis |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Testing Medicinal Plants from Uganda for HIV Latency Reversing Activity |
Emmanuel Mande, BSc |
Drug and Diagnostics Development |
|
|
MitraClip China Trial CRD956 |
Atif N. Qasim, MD |
Cardiovascular Disease, Drug and Diagnostics Development |
|
|
Tackling Tuberculous Meningitis on the Ground: Bringing Advanced Diagnostics to Uganda |
Prashanth Ramachandrani, MBBS |
Tuberculosis, Drug and Diagnostics Development, Neurology and Mental Health, Training International Scholars and Clinicians |
|
|
Redefining Tuberculous Meningitis Diagnostics with Metagenomic Next Generation Sequencing |
Prashanth Ramachandran, MBBS |
Tuberculosis, Drug and Diagnostics Development |
|
|
New Serological Measures of Infectious Disease Transmission Intensity |
Benjamin F. Arnold, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|